| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |